Evidence map›Paper›PMID 36533247›Full record

ArticleFrontiers in pediatrics2022

Organizational characteristics of European pediatric onco-critical care: An international cross-sectional survey.

Jeppe S A Nielsen, Rachel Agbeko, Jessica Bate, Iolanda Jordan, Christian Dohna-Schwake, Jenny Potratz, Andrea Moscatelli, Gabriella Bottari, John Pappachan, Volker Witt and 9 more

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Jeppe S A NielsenDepartment of Neonatal and Pediatric Intensive Care, Rigshospitalet, Copenhagen, Denmark.
Rachel AgbekoDepartment of Pediatric Intensive Care Unit, Great North Children's Hospital & Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom.
Jessica BateDepartment of Pediatric Oncology, Southampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
Iolanda JordanDepartment of Pediatric Intensive Care, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.
Christian Dohna-SchwakeDepartment of Pediatric Intensive Care, University Hospital Essen, Essen, Germany.
Jenny PotratzDepartment of General Pediatrics-Intensive Care Medicine, University Children's Hospital Münster, Münster, Germany.
Andrea MoscatelliDepartment of Pediatric Intensive Care, Gaslini Hospital, Genova, Italy.
Gabriella BottariDepartment of Pediatric Intensive Care, Ospedale Pediatrico Bambino Gesù, IRCC, Rome, Italy.
John PappachanDepartment of Pediatric Intensive Care, Southampton Children's Hospital, Southamptom, United Kingdom.
Volker WittDepartment of Pediatrics, St. Anna Children's Hospital, Medical University of Vienna, Southamptom, Austria.
Roman CrazzolaraDepartment of Pediatrics, Pediatric Intensive Care Unit, Medical University of Innsbruck, Innsbruck, Austria.
Angela AmigoniDepartment of Pediatric Intensive Care, Department of Woman's and Child's Health, Padua University Hospital, Padua, Italy.
Agniezka Mizia-MalarzDepartment of Pediatric Oncology, Hematology and Chemotherapy, Medical University of Silesia, Katowice, Poland.
Mariá Sánchez MartínDepartment of Pediatric Intensive Care, Hospital Universitario La Paz, Madrid, Spain.
Jef WillemsDepartment of Pediatric Intensive Care, Ghent University Hospital, Ghent, Belgium.
Marry M van den Heuvel-EibrinkPrincess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
Luregn J SchlapbachDepartment of Intensive Care and Neonatology, and Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland.
Roelie M Wösten-van AsperenDepartment of Pediatric Intensive Care, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, Netherlands.
POKER (PICU Oncology Kids in Europe Research group) research consortium of ESPNIC (European Society of Paediatric & Neonatal Intensive Care)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Intensified treatment protocols have improved survival of pediatric oncology patients. However, these treatment protocols are associated with increased treatment-related morbidity requiring admission to pediatric intensive care unit (PICU). We aimed to describe the organizational characteristics and processes of care for this patient group across PICUs in Europe. Methods: A web-based survey was sent to PICU directors or representative physicians between February and June 2021. Results: Responses were obtained from 77 PICUs of 12 European countries. Organizational characteristics were similar across the different countries of Europe. The median number of PICU beds was 12 (IQR 8-16). The majority of the PICUs was staffed by pediatric intensivists and had a 24/7 intensivist coverage. Most PICUs had a nurse-to-patient ratio of 1:1 or 1:2. The median numbers of yearly planned and unplanned PICU admissions of pediatric cancer patients were 20 (IQR 10-45) and 10 (IQR 10-30, respectively. Oncology specific practices within PICU were less common in participating centres. This included implementation of oncology protocols in PICU (30%), daily rounds of PICU physicians on the wards (13%), joint mortality and morbidity meetings or complex patients' discussions (30% and 40%, respectively) and participation of parents during clinical rounds (40%). Conclusion: Our survey provides an overview on the delivery of critical care for oncology patients in PICU across European countries. Multidisciplinary care for these vulnerable and challenging patients remains complex and challenging. Future studies need to determine the effects of differences in PICU organization and processes of care on patients' outcome.

Indexed as

intensive careoncologyorganizationpediatricPICUstructure

Identifiers

PMID36533247
PMCPMC9751627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.